WntRx Pharmaceuticals
PrivateLast Round
Accelerator
Feb 29, 2016
Total Funding Raised
$1.5M
Company Overview
WntRx Pharmaceuticals operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was an Accelerator round in February 2016.
WntRx Pharmaceuticals is a biotechnology company that develops non-toxic, oncogenic-specific Wnt pathway inhibitors for the treatment of various cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WntRx Pharmaceuticals Comparables
Compare WntRx Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sapience Therapeutics | 86% | |
| StemSynergy Therapeutics, Inc. | 81% | |
| Iterion Therapeutics | 79% |
For institutional investors. Book with your work email.
WntRx Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 29, 2016 | ||||
| Accelerator | Sep 1, 2015 | ||||
| Seed | Jul 1, 2015 | ||||
| Accelerator | Jul 1, 2014 | ||||
| Angel | May 1, 2014 |
For institutional investors. Book with your work email.
WntRx Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Harvard Innovation Labs | Accelerator |
| TSV Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 29, 2016
Raised an Accelerator round with MassBio and MassCONNECT.
- Jul 1, 2014
Received funding from LabCentral.
For institutional investors. Book with your work email.
WntRx Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about WntRx Pharmaceuticals's valuation, stock price, and market status.
Is WntRx Pharmaceuticals a public or private company?
WntRx Pharmaceuticals is a private company.
What is the current stock price of WntRx Pharmaceuticals?
WntRx Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks WntRx Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is WntRx Pharmaceuticals worth (valuation)?
Valuation information for WntRx Pharmaceuticals is not publicly available.
Can I buy WntRx Pharmaceuticals stock?
WntRx Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was WntRx Pharmaceuticals's last funding round?
WntRx Pharmaceuticals's most recent funding round was Accelerator on February 29, 2016.
Who are the main investors in WntRx Pharmaceuticals?
Key investors in WntRx Pharmaceuticals include Harvard Innovation Labs, TSV Capital.
Will WntRx Pharmaceuticals IPO soon?
No public IPO plans have been announced for WntRx Pharmaceuticals.
How can I track WntRx Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in WntRx Pharmaceuticals's shares on secondary markets.